These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29581361)

  • 1. CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock): Implications on Guideline Recommendations.
    Thiele H; Desch S
    Circulation; 2018 Mar; 137(13):1314-1316. PubMed ID: 29581361
    [No Abstract]   [Full Text] [Related]  

  • 2. Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.
    Zeymer U; Werdan K; Schuler G; Zahn R; Neumann FJ; Fürnau G; de Waha S; Schneider S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):601-609. PubMed ID: 27655918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.
    de Waha S; Jobs A; Eitel I; Pöss J; Stiermaier T; Meyer-Saraei R; Fuernau G; Zeymer U; Desch S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):28-37. PubMed ID: 28703046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.
    Zeymer U; Hochadel M; Thiele H; Andresen D; Schühlen H; Brachmann J; Elsässer A; Gitt A; Zahn R
    EuroIntervention; 2015 Jul; 11(3):280-5. PubMed ID: 25136881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Thiele H; Desch S; Piek JJ; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Noc M; Huber K; Fuernau G; de Waha S; Meyer-Saraei R; Schneider S; Windecker S; Savonitto S; Briggs A; Torremante P; Vrints C; Schuler G; Ceglarek U; Thiery J; Zeymer U;
    Am Heart J; 2016 Feb; 172():160-9. PubMed ID: 26856228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.
    Farhan S; Vogel B; Montalescot G; Barthelemy O; Zeymer U; Desch S; de Waha-Thiele S; Maier LS; Sandri M; Akin I; Fuernau G; Ouarrak T; Hauguel-Moreau M; Schneider S; Thiele H; Huber K
    JAMA Cardiol; 2020 Dec; 5(12):1329-1337. PubMed ID: 32845312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
    Braik N; Guedeney P; Behnes M; Desch S; Barthélémy O; Sandri M; de Waha-Thiele S; Fuernau G; Rouanet S; Hauguel-Moreau M; Zeitouni M; Overtchouk P; Ouarrak T; Schneider S; Zeymer U; Thiele H; Montalescot G; Akin I
    Am Heart J; 2021 Feb; 232():185-193. PubMed ID: 33253678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction.
    Yang JH; Hahn JY; Song PS; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Kim YJ; Gwon HC
    Crit Care Med; 2014 Jan; 42(1):17-25. PubMed ID: 24105454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    Thiele H; Akin I; Sandri M; de Waha-Thiele S; Meyer-Saraei R; Fuernau G; Eitel I; Nordbeck P; Geisler T; Landmesser U; Skurk C; Fach A; Jobs A; Lapp H; Piek JJ; Noc M; Goslar T; Felix SB; Maier LS; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Barthelemy O; Huber K; Windecker S; Hunziker L; Savonitto S; Torremante P; Vrints C; Schneider S; Zeymer U; Desch S;
    N Engl J Med; 2018 Nov; 379(18):1699-1710. PubMed ID: 30145971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: Completeness, timing, lesion assessment, and patient status.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Aug; 74(2):95-101. PubMed ID: 31053505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revascularization strategies in cardiogenic shock after acute myocardial infarction.
    Desch S
    Curr Opin Crit Care; 2019 Aug; 25(4):379-383. PubMed ID: 31082824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acutely occluded left main coronary artery culprit in cardiogenic shock and initial percutaneous coronary intervention: a substudy of the Manitoba "no option" left main PCI registry.
    Hussain F; Nguyen T; Elmayergi N; Ducas J; Minhas K; Vo M; Kass M; Ravandi A; Parmar G; Jassal DS; Tam JW; Freed D; Menkis AH; Philipp RK
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1325-31. PubMed ID: 22913597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culprit-Only or Complete Revascularization for ST-Elevation Myocardial Infarction in Patients with and Without Shock.
    Tuttle MK; Pinto DS
    Interv Cardiol Clin; 2019 Apr; 8(2):225-234. PubMed ID: 30832944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial.
    Quayyum Z; Briggs A; Robles-Zurita J; Oldroyd K; Zeymer U; Desch S; Waha S; Thiele H
    BMJ Open; 2017 Aug; 7(8):e014849. PubMed ID: 28821512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CULPRIT-SHOCK study.
    Souza Júnior JM; Kulchetscki RM; Linhares Filho JPP; Lima EG; Serrano Junior CV
    Rev Assoc Med Bras (1992); 2018 Sep; 64(9):783-786. PubMed ID: 30672997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivessel Revascularization in Shock and High-Risk Percutaneous Coronary Intervention.
    Krishnan SK; Riley RF; Hira RS; Lombardi WL
    Interv Cardiol Clin; 2017 Jul; 6(3):407-416. PubMed ID: 28600093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will CULPRIT-SHOCK change my practice? The CULPRIT-SHOCK trial: culprit lesion-only PCI vs. multivessel PCI in patients with acute myocardial infarction and cardiogenic shock.
    Sarno G; Chieffo A; Ludman P; Witkowski A; Spaulding C; James S
    EuroIntervention; 2018 Oct; 14(8):955-958. PubMed ID: 30175965
    [No Abstract]   [Full Text] [Related]  

  • 18. Revascularization in cardiogenic shock.
    Freund A; Desch S; Thiele H
    Herz; 2020 Sep; 45(6):537-541. PubMed ID: 32548775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock.
    Park JS; Cha KS; Lee DS; Shin D; Lee HW; Oh JH; Kim JS; Choi JH; Park YH; Lee HC; Kim JH; Chun KJ; Hong TJ; Jeong MH; Ahn Y; Chae SC; Kim YJ;
    Heart; 2015 Aug; 101(15):1225-32. PubMed ID: 25855797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of retrograde left main primary percutaneous coronary intervention during cardiogenic shock: The added value of performing coronary chronic total occlusion procedures.
    Gasparini GL; Oreglia JA; Reimers B
    Int J Cardiol; 2016 Jul; 215():396-8. PubMed ID: 27128569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.